Details
of the Company’s subsidiaries which are included in these condensed consolidated financial statements as of June 30, 2026 are as
follows:
| Name of Subsidiary | | Place and Date of
Incorporation | | Percentage of
Ownership | | Principal Activities | | Avalon Healthcare System, Inc. (“AHS”) | | Delaware
May 18, 2015 | | 100% held by
ALBT | | Holding company for payroll and other expenses | | | | | | | | | | Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) | | PRC
April 29, 2016 | | 100% held by
AHS | | Not considered an operating entity | | | | | | | | | | Genexosome Technologies Inc. (“Genexosome”) | | Nevada
July 31, 2017 | | 60% held by
ALBT | | No
current activities to report; dormant | | | | | | | | | | Avalon Laboratory Services, Inc. (“Avalon Lab”) | | Delaware
October 14, 2022 | | 100% held by
ALBT | | No current activities to report; dormant | | | | | | | | | | Q&A
Distribution LLC (“Q&A Distribution”) | | Texas
May 1, 2024 | | 100% held by
ALBT | | Distributes KetoAir device | | | | | | | | | | Nexus
MergerSub Limited (“Nexus”) | | BVI
February 21, 2025 | | 100% held by
ALBT | | No current activities to report | | | | | | | | | | Avalon Quantum AI, LLC (“Avalon Quantum AI”) | | Nevada
December 5, 2025 | | 100% held by
ALBT | | Advanced Agentic AI systems, including automated video generation |
|